Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 2038.03 | 170 / 170 | 100% | 17.54 | 457 / 459 |
esophagus | 100% | 1601.39 | 1445 / 1445 | 99% | 12.93 | 182 / 183 |
bladder | 100% | 1880.62 | 21 / 21 | 98% | 16.12 | 496 / 504 |
skin | 100% | 2089.11 | 1809 / 1809 | 97% | 14.04 | 458 / 472 |
intestine | 100% | 1684.78 | 966 / 966 | 97% | 13.46 | 509 / 527 |
lung | 100% | 1820.66 | 578 / 578 | 95% | 11.82 | 1103 / 1155 |
pancreas | 100% | 1235.03 | 328 / 328 | 95% | 10.77 | 169 / 178 |
stomach | 100% | 1297.11 | 359 / 359 | 94% | 11.39 | 269 / 286 |
ovary | 100% | 1959.13 | 180 / 180 | 93% | 9.13 | 399 / 430 |
thymus | 100% | 2243.60 | 653 / 653 | 93% | 8.07 | 561 / 605 |
prostate | 100% | 2496.54 | 245 / 245 | 93% | 8.57 | 465 / 502 |
brain | 98% | 1151.69 | 2593 / 2642 | 90% | 8.00 | 631 / 705 |
breast | 100% | 1810.01 | 459 / 459 | 85% | 7.36 | 954 / 1118 |
adrenal gland | 100% | 1571.99 | 258 / 258 | 84% | 5.25 | 194 / 230 |
liver | 100% | 1353.77 | 226 / 226 | 75% | 5.44 | 304 / 406 |
kidney | 100% | 1851.45 | 89 / 89 | 64% | 4.71 | 575 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.04 | 29 / 29 |
spleen | 100% | 2470.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.38 | 1 / 1 |
adipose | 100% | 1523.91 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1156.20 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 869.81 | 848 / 861 | 0% | 0 | 0 / 0 |
muscle | 96% | 654.40 | 772 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.90 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 7.48 | 71 / 80 |
peripheral blood | 87% | 1005.65 | 806 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007005 | Biological process | mitochondrion organization |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | ATAD3B |
Protein name | ATPase family AAA domain-containing protein 3B (AAA-TOB3) ATPase family AAA domain containing 3B |
Synonyms | KIAA1273 TOB3 |
Description | FUNCTION: May play a role in a mitochondrial network organization typical for stem cells, characterized by reduced mitochondrial metabolism, low mtDNA copies and fragmentated mitochondrial network. may act by suppressing ATAD3A function, interfering with ATAD3A interaction with matrix nucleoid complexes. . |
Accessions | ENST00000308647.8 Q5T9A4 ENST00000673477.1 [Q5T9A4-1] A0A5K1VW56 |